Beta;-conglycinin embeds active peptides that inhibit lipid accumulation in 3T3-L1 adipocytes in vitro

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 22, 2008, Pages 10533-10543

  Martinez Villaluenga, Cristina ^a   Bringe, Neal A ^b   Berhow, Mark A ^c   De Mejia, Elvira Gonzalez ^a,d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b MONSANTO COMPANY   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

^d MC 051 ^*  (United States)

Author keywords

conglycinin; 3T3 L1 adipocytes; Alcalase hydrolysis; Glycinin; Soy peptides

Indexed keywords

ADIPONECTIN; BETA CONGLYCININ PROTEIN, GLYCINE MAX; BETA-CONGLYCININ PROTEIN, GLYCINE MAX; GLOBULIN; GLYCININ; SEED STORAGE PROTEIN; SOYBEAN PROTEIN; SUBTILISIN;

ADIPOCYTE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN 3T3; CHEMISTRY; DRUG EFFECT; GENETICS; GENOTYPE; HYDROLYSIS; LIPID METABOLISM; METABOLISM; MOUSE; SOYBEAN;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; GENOTYPE; GLOBULINS; HYDROLYSIS; LIPID METABOLISM; MICE; SEED STORAGE PROTEINS; SOYBEAN PROTEINS; SOYBEANS; SUBTILISINS;

GLYCINE MAX;

EID: 57849158774     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf802216b     Document Type: Article

References (60)

1. Flegal, K. M.; Graubard, B. I.; Williamson, D. F.; Gail, M. H. Excess deaths associated with underweight, overweight, and obesity. JAMA - J. Am. Med. Assoc. 2005, 293, 861-1867.
2. Paddon-Jones, D.; Westman, E.; Mattes, R. D.; Wolfe, R. R.; Astrup, A.; Westerterp-Plantenga, M. Protein, weight management, and satiety. Am. J. Clin. Nutr. 2008, 87 (Suppl.), 1558S-1561S.
3. Jürimäe, J.; Jürimäe, T. Adiponectin is a predictor of bone mineral density in middle aged premenopausal women. Osteoporosis Int. 2007, 18, 1253-1259.
4. Giannessi, D.; Maltinti, M.; Del Ry, S. Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol. Res. 2007, 56, 459-467.
5. Finkelstein, E. A.; Trogdon, J. G.; Brown, D. S.; Allaire, B. T.; Dellea, P. S.; Kamal-Bahl, S. J. The lifetime medical cost burden of overweight and obesity; implications for obesity prevention. Obesity 2008, (May 29), 1-8.
6. Stern, N.; Osher, E.; Greenman, Y. Hypoadiponectinemia as a marker of adipocyte dysfunction - part II: the functional significance of low adiponectin secretion. J. Cardiometab. Syndr. 2007, 2, 288-294.
7. Antuna-Puente, B.; Feve, B.; Feilla, S.; Feilla, S.; Bastard, J. P. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metabol. 2008, 34, 2-11.
8. Pajvani, U. B.; Hawkins, M.; Combs, T. P.; Rajala, M. W.; Doebber, T.; Berger, J. P.; Wagner, J. A.; Wu, M.; Knopps, A.; Xiang, A. H.; Utzschneider, K. M.; Kahn, S. E.; Olefsky, J. M.; Buchanan, T. A.; Scherer, P. E. Complex distribution, not absolute amount of adiponectin, correlates with thiazohdinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 2004, 272, 12152-12162.
9. Lihn, A. S.; Pedersen, S. B.; Richelsen, B. Adiponectin: action, regulation and association to insulin sensitivity. Obes. Rev. 2005, 6, 13-21.
10. Weyer, C.; Funahashi, T.; Tanaka, S.; Hotta, K.; Matsuzawa, Y.; Pratley, R. E.; Tataranni, P. A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86, 1930-1935.
11. Bacha, F.; Saad, R.; Gungor, N.; Arslanian, S. A. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and β-cell function. Diabetes Care 2004, 27, 1519-1520.
12. Iau, D.; Yan, H.; Kermouni, A.; Lau, D. C. Adipokines and the paracrine control of their production in obesity and diabetes. Int. J. Obes. Relat. Metab. Disord. 2002, 26, S111.
13. Yamauchi, T.; Hara, K.; Kubota, N.; Terauchi, Y.; Tobe, K.; Froguel, P.; Nagai, R.; Kadowaki, T. Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2003, 3, 243-254.
14. Fernyhough, M. E.; Bucci, L. R.; Hausman, G. J.; Antonio, J.; Vierck, J. L.; Dodson, M. V. Gaining a solid grip on adipogenesis. Tissue Cell 2005, 37, 335-338.
15. Barrett, J. R. The science of soy: what do we really know? Environ. Health Perspect. 2006, 114, A352-358.
16. Grieshop, C. M.; Fahey, G. C., Jr. Comparison of quality characteristics of soybeans from Brazil, China, and the United States. J. Agric. Food Chem. 2001, 49, 2669-2673.
17. Grieshop, C. M.; Kadzene, C. T.; Clapper, G. M.; Flickinger, E. A.; Bauer, L. L.; Frazier, R. L.; Fahey, G. C., Jr. Chemical and nutritional characteristics of United States soybeans and soybean meals. J. Agric. Food Chem. 2003, 51, 7684-7691.
18. Panthee, D. R.; Kwanyuen, P.; Sams, C. E.; West, D. R.; Saxton, A. M.; Pantalone, V. R. Quantitative trait loci for β-conglyinin (7S) and glycinin (11S) fractions of soybean storage protein. JAOCS 2004, 81, 1005-1012.
19. Ji, M. P.; Cai, T. D.; Chang, K. C. Tofu yield and textural properties from three soybean cultivars as affected by ratios of 7S and 11S proteins. J. Food Sci. 1999, 64, 763-767.
20. Liu, K. S. Soybeans: Chemistry, Technology and Utilization; Chapman and Hall: New York, 1997; pp 532.
21. Nielsen, N. C. Soybean seed composition In Soybean: Genetics, Molecular Biology and Biotechnology; Verma, D. P. S., Shoemaker, R. G, Eds.; CAB International: Wallingford, U.K., 1996; pp 127-163.
22. Foltz, M.; Ansems, P.; Schawrz, J.; Tasker, M. C.; Lourbakos, A.; Gerhardt, C. C. Protein hydrolysates induce CCK release from enteroendocrine cells and act as partial agonist of the CCK1 receptor. J. Agric. Food Chem. 2008, 56, 837-843.
23. Velasquez, M. T.; Bhathena, S. J. Role of dietary soy protein in obesity. Int. J. Med. Sci. 2007, 4, 72-82.
24. Ohr, L. M. Weighing in on weight control. Food Technol. 2005, 59, 53-55.
25. Inaba, H.; Sakai, K.; Ota, A. Body fat-decreasing agents containing peptides and glutamin, and food composition containing them. Japan: Meiji Seka Kaisha, Ltd. Jpn. Kokai Tokkyo Koho JP 2002020312 A2 23, 2002; p 5.
26. Cope, M. B.; Erdman, J. W.; Allison, D. B. The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Obesity Rev. 2008, 9, 219-235.
27. Bringe, N. A. High β-conglycinin products and their use. U.S. Patent 6,171,640 B1, 2001.
28. Wang, W.; Bringe, N. A.; Berhow, M. A.; Gonzalez de Mejia, E. β-Conglycinins among sources of bioactives in hydrolysates of different soybean varieties that inhibit leukemia cells in vitro. J. Agric. Food Chem. 2008, 56, 4012-4020.
29. Hou, S. H. J.; Chang, S. K. C. Structural characteristics of purified glycinin from soybeans stored under various conditions. J. Agric. Food Chem. 2004, 52, 3792-3800.
30. Bennett, J. O.; Krishman, A. H.; Wiebold, W. J.; Krishman, H. B. Positional effect on protein and oil content and composition of soybeans. J. Agric. Food Chem. 2003, 51, 6882-6886.
31. Berhow, M. A. Modern analytical techniques for flavonoid determination. In Flavonoids in the Living Cell; Buslig, B. S., Manthey, J. A., Eds.; Adv. Exp. Med. Biol. 505; Kluwer Academic/Plenum Publishers: New York, 2002; pp 61-76.
32. Berhow, M. A.; Kong, S. B.; Duval, S. M. Complete quantification of group A and group B saponins in soybeans. J. Agric. Food Chem. 2006, 54, 2035-2044.
33. Kakade, M. L.; Swenson, D. H.; Liener, I. E. Note on determination of chymotrypsin inhibitory activity using casein. Anal. Biochem. 1970, 33, 255-258.
34. Wang, W.; Gonzalez de Mejia, E. A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. Comprehen. Rev. Food Sci. Food Saf. 2005, 4, 63-78.
35. Natarajan, S. S.; Xu, C.; Bae, H.; Bailey, B. A.; Cregan, P. B.; Caperna, T. J.; Garrett, W. M.; Luthria, D. L. Proteomic and genetic analysis of glycinin subunits of sixteen soybean genotypes. Plant Physiol. Biochem. 2007, 45, 436-444.
36. Cai, T.; Chang, K. Processing effect on soybean storage proteins and their relationship with tofu quality. J. Agric. Food Chem. 1999, 47, 720-727.
37. Moriyama, T.; Kishomoto, K.; Nagai, K.; Urade, R. I.; Ogawa, T.; Utsumi, S.; Maruyama, N.; Maebuchi, M. Soybean β-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of β-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci., Biotechnol., Biochem. 2004, 68, 352-359.
38. Kohno, M.; Hirotsuka, M.; Kito, M.; Matsuzawa, Y. Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean β-conglycinin. J. Atheroscler. Thromb. 2006, 13, 247-255.
39. U.S. Department of Agriculture, Agricultural research service USDA-Iowa State University database on the isoflavone content of foods, release 1.4; 2007; Nutrient Data Laboratory, http://www.ars.usda.gov/nutrientdata.
40. Wang, H. J.; Murphy, P. A. Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 1994, 42, 1666-1673.
41. Kanes, K.; Tisserat, B.; Berhow, M. A.; Vandercook, C. E. Phenolic composition of various tissues of Rutaceae species. Phytochemistry 1993, 32, 967-974.
42. Berhow, M. A.; Tisserat, B.; Kanes, K.; Vandercook, C. E. Survey of phenolic compounds produced in Citrus. USDA, ARS, Technical Bulletin 1856; U.S. GPO: Washington, DC. Manthey, J. A.; Grohmann, K. Flavonoids of the orange subfamily Aurantioideae. In Flavonoids in the Living System; Manthey, J. A., Buslig, B., Eds.; Advances in Experimental Medicine and Biology 439; Plenum Press: New York, 1998; pp 67-84.
43. Fenwick, D. E.; Oakenfull, D. Saponins content of soyabeans and some commercial soyabean products. J. Sci. Food Agric. 1981, 32, 273-278.
44. Nagasawa, A.; Fukui, K.; Kojima, M.; Kishida, K.; Maeda, N.; Nagaretani, H.; Hibuse, T.; Nishizawa, H.; Kihara, S.; Waki, M.; Takamatsu, K.; Funahashi, T.; Matsuzawa, Y. Divergent effects of soy protein diet on the expression of adipocytokines. Biochem. Biophys. Res. Commun. 2003, 311, 909-914.
45. Tovar, A. R.; Torre-Villalvazo, I.; Ochoa, M.; Elias, A. L.; Ortiz, V.; Aguilar-Salinas, C. A.; Torres, N. Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucher fa/fa rats. J. Lipid. Res. 2005, 46, 1823-1832.
46. Torre-Villalvazo, I.; Tovar, A. R.; Ramos-Barragan, V. E.; Cerbon-Cervantes, M. A.; Torres, N. Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J. Nutr. 2008, 138, 462-468.
47. Fukui, K.; Kojima, M.; Tachibana, N.; Kohno, M.; Takamatsu, K.; Hirotsuka, M.; Kito, M. Effects of soybean β-conglycinin on hepatic lipid metabolism and fecal lipid excretion in normal adult rats. Biosci., Biotechnol., Biochem. 2004, 68, 1153.
48. Fu, Y.; Luo, N.; Klein, R. L.; Garvey, W. T. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J. Lipid Res. 2005, 46, 1369-1379.
49. Nedvidkova, J.; Smitka, K.; Kopsky, V.; Hainer, V. Adiponectin, an adipocyte-derived protein. Physiol. Res. 2005, 54, 133-140.
50. Buemann, B.; Astrup, A.; Pedersen, O.; Black, E.; Hoist, C.; Toubro, S.; Echwald, S.; Hoist, J. J.; Rasmussen, C.; Sørensen, T. I. Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids. J. Clin. Endocrinol. Metab. 2006, 91, 1698-704.
51. Rasmussen, M. S.; Lihn, A. S.; Pedersen, S. B.; Bruun, J. M.; Rasmussen, M.; Richelsen, B. Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity 2006, 14, 28-35.
52. Qi, L.; Doria, A.; Manson, J E.; Meigs, J. B.; Hunter, D.; Mantzoros, C. S.; Hu, F. B. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes 2006, 55, 1512-1516.
53. Spranger, J.; Verma, S.; Gohring, I.; Bobbert, T.; Seifert, J.; Sindler, A. L.; Pfeiffer, A.; Hileman, S. M.; Tschop, M.; Banks, W. A. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006, 55, 141-147.
54. Kim, L. M. Soy and tea components inhibit in vitro adipogenesis Master's thesis, University of Illinois, Urbana-Champaign, 2007; p 120.
55. Hsu, C.-L.; Yen, G.-C. Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J. Agric. Food Chem. 2007, 55, 8404-8410.
56. Hwang, J. T.; Park, I. J.; Shin, J. I.; Lee, Y. K.; Lee, S. K.; Baik, H. W.; Ha, J.; Park, O. J. Genistein, EGCG, and capsaicin inhibit adipocytes differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 2005, 338, 694-699.
57. Wold, S. PLS for multivariate linear modeling. In QSAR: Chemometric Methods in Molecular Design. Methods and Principles in Medicinal Chemistry; Van de Waterbeemd, H., Ed.; Wiley-VCH Verlag-Chemie: Weinheim, Germany, 1995; pp 359.
58. Muszynki, I. C.; Scapozza, L.; Kovar, K. L.; Folkers, G. Quantitative structure-activity relationships of phenyltropanes as inhibitors of three monoamine transporters: classical and CoMFA studies. Quant. Struct. Act. Relat. 1999, 18, 342-352.
59. Nishi, T.; Hara, H.; Tomita, F. Soybean β-conglycinin peptone suppresses food intake and gastric emptying by increasing plasma cholecystokinin levels in rats. J. Nutr. 2003, 133, 352-357.
60. Duranti, M.; Lovati, M. R.; Dani, V.; Barbiroli, A.; Scarafoni, A.; Castiglioni, S.; Ponzone, C.; Morazzoni, P. The α subunit from soybean 7S globulin lowers plasma lipids and upregulates liver β-VLDL receptors in rats fed a hypercholesterolemi diet. J. Nutr. 2004, 134, 1334-1339.